glp-1/how-semaglutide-works-weight-loss">Semaglutide is given as a subcutaneous injection — into the layer of fat just beneath the skin, not into muscle or a vein. For most people using the weekly weight-management or diabetes pens, this is a small, fine-needle injection done once a week at home. It is straightforward once learned, but the details matter: where you inject, how you rotate sites, how you handle the device, and how you store it all affect both comfort and how reliably the medication is absorbed.
This guide walks through the approved injection sites, the technique that tends to work well, and the mistakes that come up most often. It is general educational information, not a substitute for the instructions that come with your specific device or for the guidance of the clinician and pharmacist who prescribed it. Pens differ — single-dose and multi-dose versions, fixed and adjustable doses — and the manufacturer's instructions for your exact pen always take precedence over anything written here. If you have not yet been shown how to inject by a healthcare professional, that demonstration is worth asking for before your first dose.
Why Semaglutide Is Injected Under the Skin
Semaglutide is a peptide — a short chain of amino acids modelled on the natural gut hormone GLP-1. As Daniel Drucker's 2018 review in Cell Metabolism describes, native GLP-1 is destroyed within about two minutes by an enzyme in the blood, which is why a usable medication had to be engineered to survive far longer. Semaglutide was redesigned — partly by attaching a fatty-acid chain that binds to albumin in the blood — so that a single dose lasts roughly a week. That long action is exactly why it is injected just once weekly rather than swallowed daily or injected several times a day. The fuller account of how this molecule works sits in our pillar guide to GLP-1 medications and weight science.
The injection goes into subcutaneous fat because that tissue absorbs the drug slowly and steadily, releasing it into the bloodstream over days. Injecting into muscle would speed absorption unpredictably and tends to hurt more; injecting too shallowly, into the skin itself, can cause irritation and poor absorption. The large randomised trials that established these medications — John Wilding's STEP 1 trial of once-weekly semaglutide (2021) and Ania Jastreboff's SURMOUNT-1 trial of tirzepatide (2022) — all delivered the drug by weekly subcutaneous injection, and that is the route the dosing and effects are built around.
The Approved Injection Sites
There are three approved subcutaneous sites for semaglutide. All three work equally well, and you can use any of them at any dose — the choice is about what is comfortable and easy for you to reach and rotate.
- The abdomen (belly). The most commonly used site. Inject into the soft area roughly a hand's width around the navel, but stay at least 5 cm (about two inches) away from the navel itself, where the tissue is tougher. The abdomen is easy to see and pinch, which is why many people find it the simplest place to start.
- The front or outer thigh. Use the fleshy area on the top or outer side of the upper leg, roughly midway between hip and knee. Avoid the inner thigh and the area directly over the kneecap.
- The back of the upper arm. The fatty area on the back of the upper arm is approved, but it is hard to pinch and inject one-handed on yourself. Most people use the arm only if someone else is giving the injection.
Wherever you inject, choose skin that is healthy — not bruised, scarred, tender, hardened, reddened, broken, or marked by stretch marks where the tissue may absorb differently. Do not inject through clothing.
| Site | Ease of self-injection | Notes |
|---|---|---|
| Abdomen | Easiest | Stay ≥5 cm from the navel; easy to pinch and see |
| Thigh | Easy | Front or outer thigh; avoid inner thigh and knee |
| Upper arm (back) | Difficult alone | Best done by another person |
Why Site Rotation Matters
Injecting into the same exact spot week after week can, over time, cause lipohypertrophy — small lumps of thickened or scarred fatty tissue under the skin. These lumps are not just cosmetic: tissue that has been damaged this way absorbs medication erratically, which can make a weekly dose less predictable. Rotating sites is the simplest way to prevent this.
A practical approach is to keep using the same general body area for a stretch of time but to move the precise injection point each week — keeping each new spot at least 2–3 cm (roughly an inch) from the last. Some people prefer to alternate regions (abdomen one week, thigh the next); either system works as long as you are not repeatedly hitting the same patch of skin. It helps to keep a simple log or use a phone reminder noting where the last injection went. Building this into the broader routine — alongside the habits covered in what to expect in the first month on GLP-1 — makes it easy to stay consistent.
Before each injection, glance at and gently feel the area you are about to use. If you notice a lump, firm patch, bruise, or tender spot, choose a different location and let that area recover.
Step by Step: Good Injection Technique
The exact steps depend on your device, so read the instruction leaflet for your specific pen first. The following is a general sequence that reflects how most weekly semaglutide pens are used.
1. Prepare
- Wash your hands with soap and water.
- Check the pen: confirm it is semaglutide, that it has not expired, and that the liquid is clear and colourless. Do not use it if the liquid is cloudy, discoloured, or contains particles.
- If your pen has been refrigerated, many people find the injection more comfortable if the pen is allowed to reach room temperature first — check whether your device's instructions permit this.
- Attach a new needle if your pen uses replaceable needles, and prime it exactly as the leaflet directs to remove air and confirm flow.
- Dial or confirm the correct dose. Your dose changes over the first weeks of treatment as you titrate up — see the semaglutide dosing schedule for how that escalation works, and never adjust the dose yourself without your prescriber.
2. Choose and clean the site
- Pick a site that differs from last week's. Clean it with an alcohol swab and let it air-dry; injecting into wet alcohol can sting.
3. Inject
- If your instructions call for it, gently pinch a fold of skin. Insert the needle as directed — usually straight in at 90 degrees with the short, fine needles these pens use.
- Press the dose button fully and hold. Most pens require you to keep the needle in place for several seconds (often a slow count to six or as the leaflet states) after the dose indicator returns to zero, to ensure the full dose is delivered.
- Withdraw the needle at the same angle it went in. A small amount of bleeding or a tiny bruise is normal; press gently with a clean cotton pad but do not rub the site.
4. Dispose and record
- Place the used needle or pen straight into an approved sharps container — never a household bin. Ask your pharmacy how to obtain a sharps bin and how to return it for disposal.
- Note the date and site so next week's injection lands somewhere new.
Pick a consistent day of the week for your injection. If needed, the day can be changed as long as it has been at least 48 hours since the last dose — but confirm timing rules in your device's instructions or with your pharmacist rather than guessing.
Storing and Handling the Pen
Storage affects whether the medication stays effective, so it is worth getting right. General principles for most semaglutide pens — always confirmed against your own product's leaflet — are:
- Before first use: keep the pen refrigerated, typically at 2–8°C. Do not freeze it. A pen that has been frozen should not be used, even after thawing.
- After first use: many multi-dose pens can be kept either refrigerated or at room temperature for a defined number of days (commonly several weeks) — the leaflet specifies the exact limit and temperature for your device.
- Keep the pen cap on between uses to protect it from light, and store it away from direct heat and sunlight.
- Do not use a pen past its expiry date or past the in-use period after first opening.
- Keep pens and needles out of the reach of children.
If a pen has been left out too long, exposed to heat, frozen, or you are simply unsure whether it is still good, do not guess — ask your pharmacist before injecting. The cluster of related practical guides in our GLP-1 knowledge hub covers more of the day-to-day logistics of treatment.
Common Mistakes to Avoid
- Injecting into the same spot every week. The leading cause of lumps and erratic absorption. Rotate.
- Injecting too close to the navel, or over scars, bruises, or stretch marks. These tissues absorb unevenly.
- Going into muscle. Pinching a skin fold and using the supplied short needle helps keep the dose in the subcutaneous layer, where it belongs.
- Removing the needle too soon. Pulling out before the hold time can leave part of the dose undelivered. Count it out.
- Reusing needles. A fresh needle each time is sharper, cleaner, and less painful, and reduces infection risk.
- Not letting alcohol dry, which causes unnecessary stinging.
- Skipping the room-temperature step when permitted — cold medication can sting more on the way in.
- Trying to "make up" a forgotten dose by doubling. Never double up. Follow the missed-dose rules in your leaflet, which depend on how many days have passed, and check with your pharmacist if unsure.
- Adjusting your own dose to chase faster results. Dose escalation is deliberately gradual to limit side effects, as covered in the checklist before starting a GLP-1.
It is worth noting that the most common side effects of semaglutide — nausea, reduced appetite, and other gastrointestinal effects seen across trials such as Wilding's STEP 1 — come from the drug's action on the gut and brain, not from injection technique. Drucker's mechanistic work and Liselotte van Bloemendaal's 2014 imaging study describe how GLP-1 slows stomach emptying and quiets appetite-related brain activity; that is the source of early nausea, and it is managed mainly through how and what you eat, not through where you inject. Practical strategies are set out in managing nausea on GLP-1 and what to eat on GLP-1.
When to Contact a Clinician
Most injection-site reactions are minor — a little redness, mild itching, a small bruise — and settle on their own. Contact your prescriber, pharmacist, or another healthcare professional promptly if you notice any of the following:
- Signs of infection at a site: spreading redness, warmth, swelling, increasing pain, or pus.
- A persistent lump, hardened area, or skin change that does not resolve.
- Signs of a serious allergic reaction — facial or throat swelling, difficulty breathing, widespread rash — which require emergency care immediately.
- Severe or persistent abdominal pain (especially pain radiating to the back), which warrants urgent assessment.
- Repeated trouble injecting, a malfunctioning pen, or uncertainty about your dose or schedule.
- Side effects that are severe, not improving, or interfering with eating and hydration.
None of this is a reason for anxiety about a routine weekly injection — millions of people give themselves these injections without difficulty. But semaglutide is a prescription medication for a reason, and the technique, storage, and dosing are part of using it safely. When in doubt about anything — a site that looks wrong, a pen you are unsure about, a dose you may have missed — the safest move is to ask the professional who prescribed it rather than to improvise. The medication does real, ongoing work, and as the STEP 4 trial led by Domenica Rubino (2021) and the STEP 1 extension reported by Wilding (2022) both showed, that benefit depends on consistent, correctly delivered weekly dosing over the long term. Good injection habits are simply how that consistency is maintained.
Scientific References
8 sources- 1
Wilding JPH, Batterham RL, Calanna S, et al.
Once-weekly Semaglutide in Adults with Overweight or Obesity
New England Journal of Medicine · 384(11) · 2021PMID: 33567185
NEJM - 2
Jastreboff AM, Aronne LJ, Ahmad NN, et al.
Tirzepatide Once Weekly for the Treatment of Obesity
New England Journal of Medicine · 387(3) · 2022PMID: 35658024
NEJM - 3
Drucker DJ
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Cell Metabolism · 27(4) · 2018PMID: 29617641
PubMed - 4
van Bloemendaal L, IJzerman RG, ten Kulve JS, et al.
GLP-1 Receptor Activation Modulates Appetite- and Reward-related Brain Areas in Humans
Diabetes · 63(12) · 2014PMID: 24953787
PubMed - 5
Rubino D, Abrahamsson N, Davies M, et al. (STEP 4)
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial
JAMA · 325(14) · 2021PMID: 33755728
PubMed - 6
Wilding JPH, Batterham RL, Davies MJ, et al.
Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide: The STEP 1 Trial Extension
Diabetes, Obesity and Metabolism · 24(8) · 2022PMID: 35441470
PubMed - 7
Sumithran P, Prendergast LA, Delbridge E, et al.
Long-term Persistence of Hormonal Adaptations to Weight Loss
New England Journal of Medicine · 365(17) · 2011PMID: 22011582
NEJM - 8
Müller MJ, Geisler C, Heymsfield SB, Bosy-Westphal A
Recent Advances in Understanding Body Weight Homeostasis in Humans
F1000Research · 7 · 2018PMID: 30090625
PubMed
References open in a new tab. Content is reviewed against peer-reviewed literature as part of our editorial policy.
About the author
Modern Weight Science Editorial Team
Editorial Team
Evidence-based research and educational content focused on metabolism, appetite regulation, and sustainable weight management. Our team synthesizes peer-reviewed research into clear, accessible guidance for informed health decisions.
Every claim is checked against peer-reviewed research through our review process and fact-checking policy.
Frequently Asked Questions
Where can I inject semaglutide?
There are three approved subcutaneous sites: the abdomen (stay at least 5 cm / two inches away from the navel), the front or outer thigh, and the back of the upper arm. All three work equally well. The abdomen and thigh are easiest to reach for self-injection; the upper arm is usually used only when someone else gives the injection. Always inject into healthy skin and avoid areas that are bruised, scarred, tender, hardened, or marked by stretch marks.
Does it matter which site I choose for absorption?
For weekly semaglutide, the three approved sites absorb the medication comparably, so the choice is mainly about comfort and ease of rotation. What matters more is rotating the exact spot within your chosen area each week. Injecting repeatedly into the same point can cause lipohypertrophy — lumps of thickened tissue that absorb medication unpredictably — which can make your weekly dose less reliable.
How do I rotate injection sites correctly?
Keep each new injection at least 2–3 cm (about an inch) from the previous one. You can stay within one body area and move the precise spot each week, or alternate between areas such as abdomen and thigh. Before injecting, look at and gently feel the area; if you find a lump, bruise, or tender patch, use a different spot. Keeping a simple log or phone note of where each dose went makes consistent rotation easy.
How should I store my semaglutide pen?
Before first use, keep the pen refrigerated (typically 2–8°C) and never freeze it — a frozen pen should be discarded. After first use, many multi-dose pens can be kept refrigerated or at room temperature for a defined number of days; the exact limit is in your device's leaflet. Keep the cap on to protect from light, store away from heat and direct sun, and keep it out of children's reach. If a pen has been frozen, overheated, or left out too long, ask your pharmacist before using it.
What if I forget a dose or inject on the wrong day?
Never double up to make up a missed dose. The correct action depends on how many days have passed since the missed injection, and your product's leaflet gives specific missed-dose rules. The injection day can usually be changed as long as at least 48 hours have passed since the last dose. If you are unsure what to do, contact your pharmacist or prescriber rather than guessing.
Is it normal to bruise or feel a sting when I inject?
A small amount of bleeding, a minor bruise, or brief stinging is common and not a cause for concern. You can reduce stinging by letting the alcohol swab dry fully before injecting and, where your device permits, allowing a refrigerated pen to reach room temperature first. Press gently with a clean pad afterward rather than rubbing. Contact a clinician if a site becomes increasingly red, warm, swollen, painful, or shows pus, which can signal infection.
When should I contact a clinician about an injection?
Seek advice for signs of infection (spreading redness, warmth, swelling, increasing pain, or pus), a persistent lump or skin change, a malfunctioning pen, or uncertainty about your dose or schedule. Seek emergency care immediately for signs of a serious allergic reaction such as facial or throat swelling, difficulty breathing, or a widespread rash, and seek urgent assessment for severe abdominal pain. When in doubt, ask the professional who prescribed the medication.
Continue learning
Where to read next
Not medical advice. This guide is for general education only. GLP-1 medications, dosing, and treatment suitability are decisions for you and a licensed clinician who knows your full medical history.

